Inflammation is an amplifier of lung congestion by high lv filling pressure in hemodialysis patients: a longitudinal study.
Fiche publication
Date publication
janvier 2020
Journal
Journal of nephrology
Auteurs
Membres identifiés du Cancéropôle Est :
Pr ROSSIGNOL Patrick
Tous les auteurs :
Torino C, Gargani L, Sicari R, Letachowicz K, Ekart R, Fliser D, Covic A, Siamopoulos K, Stavroulopoulos A, Massy ZA, Fiaccadori E, Regolisti G, Bachelet T, Slotki I, Martinez-Castelao A, Coudert-Krier MJ, Rossignol P, Hannedouche T, Wiecek A, Sarafidis P, Battaglia Y, Prohić N, Klinger M, Hojs R, Seiler-Mußler S, Lizzi F, Siriopol D, Balafa O, Shavit L, Loutradis C, Seidowsky A, Tripepi R, Mallamaci F, Tripepi G, Picano E, London GM, Zoccali C
Lien Pubmed
Résumé
Since inflammation alters vascular permeability, including vascular permeability in the lung, we hypothesized that it can be an amplifier of lung congestion in a category of patients at high risk for pulmonary oedema like end stage kidney disease (ESKD) patients.
Mots clés
Cardiovascular risk, ESRD, Hemodialysis, Inflammation, Lung congestion, Pulmonary edema
Référence
J. Nephrol.. 2020 Jan 8;: